Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: a new physiological concept

被引:7
|
作者
Demacker, PNM [1 ]
Hectors, MPC [1 ]
Stalenhoef, AFH [1 ]
机构
[1] Univ Nijmegen Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
关键词
lipoproteins; apolipoprotein B-48; lipid transfer or diffusion; postprandial phase; vitamin A; vitamin E; familial dysbetalipoproteinemia; familial combined hyperlipidemia;
D O I
10.1016/S0021-9150(99)00326-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In previous work we identified a transfer/diffusion process occurring in the postprandial state that more or less contributes to the accumulation of beta-VLDL in familial dysbetalipoproteinemia (FD). Here we present a new theoretical concept underlying chylomicron processing developed on the basis of extended quantitative analyses of fat loading experiments, with both vitamins A and E, performed in patients with familial combined hyperlipidemia (FCH) in comparison to patients with FD and control subjects. Recovery of triglycerides from the fat load in the plasma triglyceride pool was < 4%, indicating a very effective lipolysis process with an active remnant generation. Vitamin A from the fat load was, over 48 h, quantitatively recovered in the plasma lipoprotein pool; vitamin E was recovered to 22-41%. Nevertheless, transfer/diffusion of both vitamins showed similar patterns. At equilibrium, their contents correlated strongly with the lipoprotein concentrations, the slopes being similar for control subjects and both groups of patients. Only in those FD patients with the highest lipid values, did the vitamin A/lipoprotein mass ratio in the Sf > 100 fraction deviate from the total group mean. In the Sf 15-100 fraction, most specific for 'remnants', vitamin A/cholesterol ratios for all subjects were uniform proving that beta-VLDL formation is a thermodynamic process regulated by concentration gradients and the lipophilicity of lipoprotein constituents, not a typical feature for patients with FD. In patients with FD, vitamin A in the plasma pool was recovered excessively (276%) in line with recognition in Various pools as a result of the transfer/diffusion process in plasma. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:169 / 180
页数:12
相关论文
共 32 条
  • [1] IMPAIRED CHYLOMICRON REMNANT CLEARANCE IN FAMILIAL COMBINED HYPERLIPIDEMIA
    CABEZAS, MC
    DEBRUIN, TWA
    JANSEN, H
    KOCK, LAW
    KORTLANDT, W
    ERKELENS, DW
    ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (06): : 804 - 814
  • [2] Inflammatory markers in familial combined hyperlipidemia
    Gentile, M.
    Pauciullo, P.
    Ubaldi, S.
    Marotta, G.
    Jossa, R.
    Iannuzzo, G.
    Faccenda, F.
    Rubba, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 282 - 282
  • [3] SIMVASTATIN IMPROVES CHYLOMICRON REMNANT REMOVAL IN FAMILIAL COMBINED HYPERLIPIDEMIA WITHOUT CHANGING CHYLOMICRON CONVERSION
    CABEZAS, MC
    DEBRUIN, TWA
    KOCK, LAW
    KORTLANDT, W
    TRIP, MV
    JANSEN, H
    ERKELENS, DW
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (04): : 497 - 503
  • [4] Low plasma vitamin A concentrations in familial combined hyperlipidemia
    Ribalta, J
    LaVille, AE
    Girona, J
    Vallvé, JC
    Masana, L
    CLINICAL CHEMISTRY, 1997, 43 (12) : 2379 - 2383
  • [5] Endothelial haemostatic markers in members of families with familial combined hyperlipidemia
    Karásek, D
    Vaverková, H
    Hutyra, M
    Novotny, D
    Budíková, M
    Slavík, L
    FRONTIERS IN CORONARY ARTERY DISEASE, 2003, : 355 - 358
  • [6] Endothelial haemostatic markers in members of families with familial combined hyperlipidemia
    Karasek, David
    Vaverkva, Helena
    Halenka, Milan
    Slavik, Ludek
    Novotny, Dalibor
    THROMBOSIS RESEARCH, 2009, 123 (03) : 466 - 475
  • [7] Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment
    Inka Miñambres
    Jose Luis Sánchez-Quesada
    Joan Sánchez-Hernández
    Jose Rodríguez
    Alberto de Leiva
    Antonio Pérez
    Diabetology & Metabolic Syndrome, 6
  • [8] Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment
    Minambres, Inka
    Sanchez-Quesada, Jose Luis
    Sanchez-Hernandez, Joan
    Rodriguez, Jose
    de Leiva, Alberto
    Perez, Antonio
    DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [9] Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia
    Solanas-Barca, Maria
    de Castro-Oros, Isabel
    Mateo-Gallego, Rocio
    Cofan, Montserrat
    Plana, Nuria
    Puzo, Jose
    Burillo, Elena
    Martin-Fuentes, Paula
    Ros, Emilio
    Masana, Luis
    Pocovi, Miguel
    Civeira, Fernando
    Cenarro, Ana
    ATHEROSCLEROSIS, 2012, 222 (02) : 449 - 455
  • [10] Calculating LDL cholesterol in familial combined hyperlipidemia: Out with the old, in with the new?
    Martin, Seth S.
    ATHEROSCLEROSIS, 2018, 277 : 172 - 174